Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Mortensen, J. Skouv, D. Hougaard, L. Larsson (1999)
Endogenous Endothelial Cell Nitric-oxide Synthase Modulates Apoptosis in Cultured Breast Cancer Cells and Is Transcriptionally Regulated by p53*The Journal of Biological Chemistry, 274
A. Bonni, A. Brunet, A. West, S. Datta, M. Takasu, M. Greenberg (1999)
Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.Science, 286 5443
R. Asslan, A. Pradines, C. Pratx, C. Allal, G. Favre, F. Gaillard (1999)
Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells.Biochemical and biophysical research communications, 260 3
K. Mortensen, L. Larsson (2003)
Effects of cytochalasin D on the actin cytoskeleton: association of neoformed actin aggregates with proteins involved in signaling and endocytosisCellular and Molecular Life Sciences CMLS, 60
E. Mimnaugh, C. Chavany, L. Neckers (1996)
Polyubiquitination and Proteasomal Degradation of the p185c-erbB-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin*The Journal of Biological Chemistry, 271
F. Denizot, R. Lang (1986)
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.Journal of immunological methods, 89 2
T. Schulte, M. Blagosklonny, C. Ingui, L. Neckers (1995)
Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association (*)The Journal of Biological Chemistry, 270
J. Weber, Weimin Hu, S. Jefcoat, D. Raben, J. Baldassare (1997)
Ras-stimulated Extracellular Signal-related Kinase 1 and RhoA Activities Coordinate Platelet-derived Growth Factor-induced G1 Progression through the Independent Regulation of Cyclin D1 and p27KIP1 *The Journal of Biological Chemistry, 272
F. González, A. Seth, D. Raden, D. Bowman, F. Fay, R. Davis (1993)
Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleusThe Journal of Cell Biology, 122
Alberto Piccinotti, Giuliana Benaglia, R. Bresciani, D. Zizioli, M. Presta, A. Preti, S. Marchesini (2000)
Nerve growth factor induces sphingomyelin accumulation in pheochromocytoma cellsFEBS Letters, 472
H. Joensuu, P. Roberts, M. Sarlomo‐Rikala, Leif Andersson, P. Tervahartiala, D. Tuveson, D. Tuveson, S. Silberman, R. Capdeville, S. Dimitrijević, B. Druker, G. Demetri (2001)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.The New England journal of medicine, 344 14
S. Venkateswarlu, D. Dawson, P. Clair, Anjana Gupta, J. Willson, M. Brattain (2002)
Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cellsOncogene, 21
Hong He, Y. Hirokawa, E. Manser, L. Lim, A. Levitzki, Hiroshi Maruta (2001)
Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation.Cancer journal, 7 3
P. Houghton, G. Germain, F. Harwood, J. Schuetz, C. Stewart, E. Buchdunger, P. Traxler (2004)
Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in VitroCancer Research, 64
Z. Nie, Y. Mei, R. Malek, A. Marcuzzi, N. Lee, V. Ramkumar (1999)
A role of p75 in NGF-mediated down-regulation of the A(2A) adenosine receptors in PC12 cells.Molecular pharmacology, 56 5
P. Traxler, G. Bold, E. Buchdunger, G. Caravatti, P. Furet, P. Manley, T. O'reilly, J. Wood, J. Zimmermann (2001)
Tyrosine kinase inhibitors: From rational design to clinical trialsMedicinal Research Reviews, 21
A. Levitzki, A. Gazit (1995)
Tyrosine kinase inhibition: an approach to drug development.Science, 267 5205
S. Tsai, P. Chiu, C. Yang, Y. Lee (2002)
Synergistic effects of corticosterone and kainic acid on neurite outgrowth in axotomized dorsal root ganglionNeuroscience, 114
M. Favata, K. Horiuchi, E. Manos, A. Daulerio, Deborah Stradley, W. Feeser, D. Dyk, W. Pitts, R. Earl, F. Hobbs, R. Copeland, R. Magolda, P. Scherle, J. Trzăskos (1998)
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*The Journal of Biological Chemistry, 273
P. Lenormand, C. Sardet, G. Pagès, G. l'Allemain, A. Brunet, J. Pouysségur (1993)
Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblastsThe Journal of Cell Biology, 122
Ming-Shyue Lee, T. Igawa, T. Yuan, Xiu-Qing Zhang, F. Lin, M. Lin (2003)
ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cellsOncogene, 22
E. Buchdunger, A. Matter, B. Druker (2001)
Bcr-Abl inhibition as a modality of CML therapeutics.Biochimica et biophysica acta, 1551 1
M. Cheng, V. Sexl, C. Sherr, M. Roussel (1998)
Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).Proceedings of the National Academy of Sciences of the United States of America, 95 3
R. Carlson, S. Aschmies (1995)
Tyrosine Kinase Activity Is Essential for Interleukin‐1β‐Stimulated Production of Interleukin‐6 in U373 Human Astrocytoma CellsJournal of Neurochemistry, 65
J. Bain, H. Mclauchlan, M. Elliott, P. Cohen (2003)
The specificities of protein kinase inhibitors: an update.The Biochemical journal, 371 Pt 1
L. Shawver, D. Slamon, A. Ullrich (2002)
Smart drugs: tyrosine kinase inhibitors in cancer therapy.Cancer cell, 1 2
L. Neckers (2002)
Hsp90 inhibitors as novel cancer chemotherapeutic agents.Trends in molecular medicine, 8 4 Suppl
M. Dieter, S. Freshwater, W. Solis, D. Nebert, T. Dalton (2001)
Tyrphostin [correction of Tryphostin] AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements.Biochemical pharmacology, 61 2
J. Lavoie, G. l'Allemain, A. Brunet, R. Müller, J. Pouysségur (1996)
Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway*The Journal of Biological Chemistry, 271
Charlyn Sarnecki, John Blenis (1992)
Nuclear localization and regulation of erk- and rsk-encoded protein kinasesMolecular and Cellular Biology, 12
A. Levitzki (1990)
Tyrphostins--potential antiproliferative agents and novel molecular tools.Biochemical pharmacology, 40 5
Franco R., Torres-Márquez M., Pasantes-Morales H. (2001)
Evidence for two mechanisms of amino acid osmolyte release from hippocampal slicesPflügers Archiv, 442
M. Ohmichi, L. Pang, V. Ribon, A. Gazit, A. Levitzki, A. Saltiel (1993)
The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.Biochemistry, 32 17
E. Buchdunger, T. O'reilly, J. Wood (2002)
Pharmacology of imatinib (STI571).European journal of cancer, 38 Suppl 5
R. Konrad, Robert Dean, R. Young, P. Billings, B. Wolf (1996)
Glucose-induced Tyrosine Phosphorylation of p125 in Beta Cells and Pancreatic IsletsThe Journal of Biological Chemistry, 271
T. Grunt (2003)
Tyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells.Cancer letters, 189 2
S. Yeh, Hui-Kuan Lin, Hong-Yo Kang, T. Thin, M. Lin, Chawnshang Chang (1999)
From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells.Proceedings of the National Academy of Sciences of the United States of America, 96 10
M. Rende, E. Brizi, J. Conner, S. Treves, K. Censier, C. Provenzano, G. Taglialatela, P. Sanna, R. Donato (2000)
Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKAInternational Journal of Developmental Neuroscience, 18
S. Martin, Chris Reutelingsperger, A. Mcgahon, James Rader, R. Schie, D. Laface, Douglas Green (1995)
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and AblThe Journal of Experimental Medicine, 182
Youmei Xie, M. Tisi, T. Yeo, F. Longo (2000)
Nerve Growth Factor (NGF) Loop 4 Dimeric Mimetics Activate ERK and AKT and Promote NGF-like Neurotrophic Effects*The Journal of Biological Chemistry, 275
Y. Yarden, M. Sliwkowski (2001)
Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2
Binding of growth factors to cell surface receptors activates protein tyrosine kinases (PTKs) that initiate cascades of downstream signaling events including the mitogen-activated protein (MAP) kinase cascade. This study reports that the PTK inhibitor AG 879 inhibits proliferation of human breast cancer cells through an effect involving inhibition of MAP kinase activation, but which cannot be explained by effects of AG 879 on its known PTK targets. Instead, AG 879 markedly inhibits expression of the RAF-1 gene, which encodes an upstream MAP kinase kinase kinase. Additionally, expression of HER-2, but not of other genes tested, is inhibited by this compound. These novel effects have to be considered when using AG 879 as a TRK-A and HER-2 inhibitor but may have useful therapeutic implications.
Cellular and Molecular Life Sciences – Springer Journals
Published: Jan 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.